Proprotein convertase subtilisin-kexin type 9 (PCSK9) inhibitor use in the management of resistant hypercholesterolemia induced by mitotane treatment for adrenocortical cancer
| Image |  |
|---|---|
| Description | scientific article published on 13 March 2018 |
| Author/s |
author: Stelios Tigas |
| Publication date | March 13, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |